Walgreens maintained its fiscal 2025 adjusted earnings guidance, but did not include a sales outlook in its release.
Related Posts
Lowe’s sticks by full-year forecast as sales from home professionals boost business
Lowe’s on Wednesday stood by its full-year forecast, despite reporting quarterly sales that fell just short of Wall Street’s expectations.
Jefferies says buy this pharmaceutical play, sees more than 100% upside from here
This pharmaceutical company’s recent drug developments could spell more gains ahead, according to Jefferies.
Anne Wojcicki has a new offer to take 23andMe private, this time for $74.7 million
23andMe CEO Anne Wojcicki and New Mountain Capital have submitted a proposal to take the company private.